https://www.selleckchem.com/pr....oducts/mpp-dihydroch
We conclude by overviewing the clinical application of biomaterials in BM and HC pathophysiology and its challenges and opportunities.Leptin has been recognized as a potential tumor growth promoter in various cancers including cranial tumor pathologies such as pituitary adenomas, meningiomas and gliomas. Despite recent advances in adjunctive therapy and the established surgical resection, chemo- and radiotherapy regimen, glioblastoma multiforme remains a particular diagnostic and therapeutic challenge among the intracranial
Like
Comment
Share
